Lithuania vs Moldova: Colon and rectum cancer screening coverage in Europe
Lithuania
57.9%
in 2024
Moldova
44.6%
in 2024
Lithuania rank
6th
Moldova rank
9th
Colon and rectum cancer screening coverage in Europe over time
- Lithuania
- Moldova
How they compare
Lithuania currently reports 57.9% against 44.6% in Moldova, a difference of 13.3%.
That makes Lithuania's figure about 1.3 times Moldova's.
Across all 8 years both countries report, Lithuania has been ahead every year.
Lithuania ranks 6th and Moldova ranks 9th of 20 countries.
Lithuania has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Lithuania | Moldova | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 53.0% | 41.7% | 11.2% | Lithuania |
| 2020s | 53.1% | 39.2% | 13.9% | Lithuania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher colon and rectum cancer screening coverage in europe, Lithuania or Moldova?
- Lithuania, at 57.9% against 44.6% in Moldova as of 2024.
- What is the difference in colon and rectum cancer screening coverage in europe between Lithuania and Moldova?
- 13.3%, with Lithuania ahead.
- How many years of comparable data are there for Lithuania and Moldova?
- 8 years are reported by both, from 2017 to 2024.
- How do Lithuania and Moldova rank globally for colon and rectum cancer screening coverage in europe?
- Lithuania ranks 6th and Moldova ranks 9th of 20 countries.
- Where does this data come from?
- Eurostat (2026) – with minor processing by Our World in Data, published as Colon and rectum cancer screening coverage in Europe. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of people aged 50 to 74 years who have been screened for colon and rectum cancer within the previous 2 years.